GenePath Dx Overview
- Year Founded
-
2008
- Status
-
Private
- Employees
-
59
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$336K
- Investors
-
3
GenePath Dx General Information
Description
Operator of a next-generation diagnostics company intended to offer in vitro diagnostic techniques such as molecular diagnostics to the medical, healthcare and allied communities. The company's diagnostic techniques such as quantitative polymerase chain reaction, multiplex ligation-dependent probe amplification and sanger and sequencing are more rapid compared to conventional microbiology and more sensitive than immunology-based tests, enabling medical, healthcare and allied communities to get accurate, reliable, rapid and affordable diagnostics results.
Contact Information
Website
www.genepathdx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Diagnostic Equipment
Primary Office
- Swastik Society Model Colony
- Manikchand Galleria, 7th Floor
- Pune, Maharashtra 411016
- India
+91 020 0000 0000
GenePath Dx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Grant | 23-Nov-2020 | $336K | 00.000 | Completed | Generating Revenue | |
| 4. Later Stage VC | 05-Jul-2017 | 00.000 | Completed | Generating Revenue | ||
| 3. Later Stage VC | 01-Feb-2016 | 00000 | 00.000 | 00.000 | Completed | Generating Revenue |
| 2. Later Stage VC | 11-Feb-2015 | $403K | $1.06M | 00.000 | Completed | Generating Revenue |
| 1. Later Stage VC | 28-Aug-2014 | $658K | $658K | 00.000 | Completed | Generating Revenue |
GenePath Dx Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | 00,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 0.000 |
GenePath Dx Patents
GenePath Dx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4034671-A1 | Composition and method for improving detection of biomolecules in biofluid samples | Pending | 24-Sep-2019 | 0000000000 | |
| US-20220396824-A1 | Composition and method for improving detection of biomolecules in biofluid samples | Pending | 24-Sep-2019 | 0000000000 | |
| EP-4034671-A4 | Composition and method for improving detection of biomolecules in biofluid samples | Pending | 24-Sep-2019 | 000000000 | 0 |
| EP-3959337-A1 | Method for detecting specific nucleic acids in samples | Pending | 24-Apr-2019 | 0000000000 | |
| EP-3959337-A4 | Method for detecting specific nucleic acids in samples | Pending | 24-Apr-2019 | C12Q1/6816 | 0 |
GenePath Dx Executive Team (9)
GenePath Dx Board Members (6)
| Name | Representing | Role | Since |
|---|---|---|---|
| Ashit Lilani | Saama Capital | Board Member & Advisor | 000 0000 |
| Ashwini Joglekar | Self | Board Member | 000 0000 |
| Christopher Kolenaty | Snow Leopard Ventures | Board Member | 000 0000 |
| Firdaus Dastoor | Self | Board Member | 000 0000 |
| Karthik Ganesan | GenePath Dx | Chief Technology Officer & Board Member | 000 0000 |
GenePath Dx Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
GenePath Dx Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| US India Science and Technology Endowment Fund | Limited Partner | 000 0000 | 000000 0 | ||
| Saama Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Snow Leopard Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |